UBS Group Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

Key Points

• UBS Group has lowered its price target for DENTSPLY SIRONA from $25.00 to $24.00, but still maintains a "buy" rating, suggesting an 85.83% potential upside.
• Other analysts have offered mixed ratings, with Morgan Stanley downgrading it to "equal weight" and a target price of $14.00, while Barrington Research set a target at $18.00 with an "outperform" rating.
• DENTSPLY SIRONA's stock recently traded down 2.4% to $12.92, with a 12-month trading range from a low of $12.16 to a high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its price target cut by equities researchers at UBS Group from $25.00 to $24.00 in a research note issued on Friday,Benzinga reports. The firm currently has a "buy" rating on the medical instruments supplier's stock. UBS Group's price target would indicate a potential upside of 85.83% from the company's current price.

Several other equities analysts have also weighed in on XRAY. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday, April 15th. Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday. Finally, Barrington Research set a $18.00 price objective on shares of DENTSPLY SIRONA and gave the stock an "outperform" rating in a report on Friday. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Trading Down 2.4%

XRAY stock traded down $0.32 during midday trading on Friday, hitting $12.92. The stock had a trading volume of 5,686,109 shares, compared to its average volume of 2,965,368. The firm has a market cap of $2.57 billion, a PE ratio of -2.84, a price-to-earnings-growth ratio of 0.97 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. DENTSPLY SIRONA has a 12-month low of $12.16 and a 12-month high of $27.48. The company's 50-day moving average price is $15.77 and its 200 day moving average price is $15.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The firm had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. During the same period in the previous year, the company earned $0.49 EPS. DENTSPLY SIRONA's revenue for the quarter was down 4.9% on a year-over-year basis. On average, equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds have recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth $25,000. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $26,000. Brooklyn Investment Group acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth $26,000. Finally, Trust Co. of Toledo NA OH acquired a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth $27,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.